Showing 841 - 860 results of 2,767 for search '(( significant decrease decrease ) OR ( significantly ((mean decrease) OR (a decrease)) ))~', query time: 0.66s Refine Results
  1. 841

    Demographics of the enrolled patients. by Yuka Kasai (21354922)

    Published 2025
    “…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”
  2. 842

    Overhead view of the eye drop aid. by Yuka Kasai (21354922)

    Published 2025
    “…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”
  3. 843
  4. 844
  5. 845
  6. 846
  7. 847
  8. 848
  9. 849
  10. 850
  11. 851

    Multi-organ differential gene expression changes statistically significant at hypertension onset. by Eden Hornung (20148295)

    Published 2024
    “…<i>Tgfb1</i> is significantly decreased in male SHR kidney compared to female at 16 weeks of age (p = 0.004). …”
  12. 852
  13. 853
  14. 854
  15. 855

    Neutrophil function assays completed on CGD patients off and after the 4<sup>th</sup> dose of IFN-γ. by Daniel R. Ambruso (12042605)

    Published 2025
    “…Bar and patient designation are as stated in <b>A.</b> Bars and brackets represent mean ± SEM with the number of subjects studied below. …”
  16. 856

    Neutrophil Superoxide anion production, Heat map for gene expression from neutrophils of CGD patients, and PCA plot for genome-wide gene expression. by Daniel R. Ambruso (12042605)

    Published 2025
    “…Heat map</b> showing changes for all significant genes between off IFN-γ and 10-12 hours after the 1st and 4th dose (50 µg/m<sup>2</sup>) of the cytokine given on a routine schedule noted in Methods. …”
  17. 857
  18. 858
  19. 859
  20. 860